Amarin Has the Makings for a Gamechanging Product

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Amarin is targeting a huge market, and its main drug -- Vascepa -- is likely to be expanded in its coverage. Here’s a look at what’s ahead for the stock.

The post Amarin Has the Makings for a Gamechanging Product appeared first on InvestorPlace.

• 2 Toxic Pot Stocks You Should Avoid
• These 7 S&P 500 Stocks Will Deliver a Repeat Performance in the Next Decade
• 7 Tech Stocks to Stuff Your Stocking With
• 7 Sinfully Good Casino Stocks That Could Win the Jackpot in 2020